Syros Pharmaceuticals (SYRS) is Initiated by H.C. Wainwright to Neutral, Price Target at $10

Syros Pharmaceuticals (SYRS) was Initiated by H.C. Wainwright to “Neutral” and the brokerage firm has set the Price Target at $10. H.C. Wainwright advised their investors in a research report released on Jul 18, 2016.

Syros Pharmaceuticals

Leave a Reply

Syros Pharmaceuticals - Is it time to Sell?

Top Brokerage Firms are advising their investors on Syros Pharmaceuticals. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.